Loading...

Santen Pharmaceutical Co., Ltd.

SNPHF•PNK
Healthcare
Drug Manufacturers - General
$10.99
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Santen Pharmaceutical Co., Ltd. (SNPHF) Stock Overview

Explore Santen Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E Ratio18.40
EPS (TTM)$0.58
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$9.69
3 Months$9.55
1 Year Target$10.30

SNPHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Santen Pharmaceutical Co., Ltd. (SNPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $10.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.40 and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
15.56%
6-Month Change
8.70%
Year-to-Date (YTD) Change
15.56%
1-Year Change
4.37%
3-Year Change
34.35%
5-Year Change
-19.19%
All-Time (Max) Change
-99.46%

Contact Information

https://www.santen.com
81 6 7664 8621
Grand Front Osaka Tower A, Osaka, NaN, 530-8552

Company Facts

3,744 Employees
IPO DateJun 9, 2010
CountryJP
Actively Trading

Frequently Asked Questions